A discourse in clinical study timelines and the need for acceleration in retina research

Conference|ARVO

Dr. David Bingaman of Ora Clinical discusses today’s need to accelerate clinical studies and increase investments in retina and challenging disease states.

David Hutton, executive editor of Ophthalmology Times®, sits down with David Bingaman, DVM, PhD, Chief Development Officer of Ora Clinical to discuss the need to accelerate clinical trials and increase investments in retina research. Dr. Bingaman also discusses Ora Clinical’s presence at ARVO 2022.

Related Videos
Related Content

Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

Study examines why episodes of low blood sugar worsen eye disease in people with diabetes

January 28th 2023

What to expect from virtual AAO 2020

November 5th 2020

Foundation Fighting Blindness to host PRPH2 and Associated Retinal Diseases Workshop

January 26th 2023

Study: More than a quarter of older Americans have visual impairment

January 17th 2023

Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

Study examines why episodes of low blood sugar worsen eye disease in people with diabetes

January 28th 2023

What to expect from virtual AAO 2020

November 5th 2020

Foundation Fighting Blindness to host PRPH2 and Associated Retinal Diseases Workshop

January 26th 2023

Study: More than a quarter of older Americans have visual impairment

January 17th 2023

Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

Study examines why episodes of low blood sugar worsen eye disease in people with diabetes

January 28th 2023

What to expect from virtual AAO 2020

November 5th 2020

Foundation Fighting Blindness to host PRPH2 and Associated Retinal Diseases Workshop

January 26th 2023

Study: More than a quarter of older Americans have visual impairment

January 17th 2023
Advertise
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.